Rituximab as Rescue or Add‐On Therapy for Relapsing or Refractory Lupus Nephritis: A Systematic Review and Meta‐Analysis
Relapsing and refractory lupus nephritis (LN) remains difficult to manage despite advances in immunosuppressive and targeted therapies. Rituximab (RTX) is often used as rescue or add‐on therapy, but renal outcomes in this specific setting have not been quantitatively synthesized. PubMed, Embase, and Web of Science were...